Sivik Global Healthcare’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,000
Closed -$7M 41
2025
Q4
$7M Sell
15,000
-2,000
-12% -$929K 2.03% 13
2025
Q3
$7.25M Sell
17,000
-8,000
-32% -$3.1M 2.11% 12
2025
Q2
$9.58M Hold
25,000
2.61% 11
2025
Q1
$8.64M Buy
25,000
+5,000
+25% +$1.61M 4.67% 4
2024
Q4
$6M Hold
20,000
3.16% 11
2024
Q3
$8.13M Sell
20,000
-5,000
-20% -$1.83M 3.44% 11
2024
Q2
$8.03M Buy
25,000
+7,500
+43% +$2.44M 2.88% 9
2024
Q1
$5.84M Sell
17,500
-22,500
-56% -$6.88M 1.37% 19
2023
Q4
$10.8M Hold
40,000
4.52% 3
2023
Q3
$9.84M Buy
40,000
+15,000
+60% +$4.1M 4.97% 1
2023
Q2
$7.59M Sell
25,000
-5,000
-17% -$1.39M 1.77% 16
2023
Q1
$7.91M Sell
30,000
-5,000
-14% -$1.27M 3.4% 7
2022
Q4
$8.4M Sell
35,000
-7,500
-18% -$1.68M 3.95% 4
2022
Q3
$7.81M Buy
42,500
+15,000
+55% +$2.99M 4.34% 1
2022
Q2
$4.62M Buy
27,500
+5,000
+22% +$1.07M 2.63% 17
2022
Q1
$5.64M Sell
22,500
-4,487
-17% -$1.13M 2.33% 19
2021
Q4
$6.93M Sell
26,987
-28,013
-51% -$6.85M 2.97% 15
2021
Q3
$13.3M Buy
55,000
+25,000
+83% +$6.11M 3.19% 3
2021
Q2
$6.2M Sell
30,000
-10,000
-25% -$2.04M 1.21% 25
2021
Q1
$7.53M Sell
40,000
-20,000
-33% -$3.53M 2.75% 16
2020
Q4
$9.87M Hold
60,000
4.02% 2
2020
Q3
$7.48M Sell
60,000
-45,000
-43% -$5.57M 3.22% 12
2020
Q2
$9.6M Buy
105,000
+10,000
+11% +$1.04M 3.18% 8
2020
Q1
$7.5M Buy
95,000
+32,500
+52% +$4.21M 2.96% 13
2019
Q4
$9.24M Buy
62,500
+2,500
+4% +$336K 3.43% 2
2019
Q3
$7.22M Buy
60,000
+20,000
+50% +$2.58M 3.65% 4
2019
Q2
$5.41M Sell
40,000
-20,000
-33% -$2.53M 1.31% 21
2019
Q1
$7.82M Buy
60,000
+25,000
+71% +$3.36M 2.88% 10
2018
Q4
$4.36M Sell
35,000
-20,000
-36% -$2.68M 2.35% 20
2018
Q3
$7.65M Buy
+55,000
New +$6.85M 2.73% 8
2018
Q2
Sell
-25,000
Closed -$2.42M 68
2018
Q1
$2.42M Sell
25,000
-60,000
-71% -$5.82M 1.13% 36
2017
Q4
$7.47M Buy
+85,000
New +$6.83M 2.77% 3
2017
Q3
Sell
-35,000
Closed -$3.05M 80
2017
Q2
$3.05M Sell
35,000
-17,500
-33% -$1.48M 1.12% 38
2017
Q1
$4.67M Buy
+52,500
New +$4.38M 2.18% 20
2016
Q3
Sell
-70,900
Closed -$5.46M 54
2016
Q2
$5.46M Sell
70,900
-54,100
-43% -$4.27M 2.71% 7
2016
Q1
$9.76M Sell
125,000
-15,000
-11% -$1.05M 4.32% 2
2015
Q4
$9.47M Buy
140,000
+55,000
+65% +$3.84M 4.5% 1
2015
Q3
$6.58M Sell
85,000
-34,300
-29% -$3.04M 3.19% 6
2015
Q2
$10.8M Buy
119,300
+24,300
+26% +$1.95M 3.76% 4
2015
Q1
$7.15M Sell
95,000
-13,600
-13% -$977K 2.43% 9
2014
Q4
$7.97M Sell
108,600
-11,400
-10% -$801K 3.23% 1
2014
Q3
$8.46M Buy
120,000
+20,000
+20% +$1.32M 3.85% 1
2014
Q2
$5.64M Buy
100,000
+11,090
+12% +$585K 2.85% 4
2014
Q1
$4.67M Sell
88,910
-21,090
-19% -$1.05M 2.91% 4
2013
Q4
$5.25M Buy
+110,000
New +$5.08M 3.73% 1

Other funds holding HCA

Sivik Global Healthcare's HCA Position: Q1 2026 in Review

Sivik Global Healthcare sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 15,000 shares — an estimated $7M sold.

Sivik Global Healthcare first reported a position in HCA in Q4 2013 and held it in 45 quarters. The position peaked at $13.3M in Q3 2021. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Sivik Global Healthcare reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
  • Sivik Global Healthcare sold 15,000 HCA Healthcare shares in Q1 2026, an estimated $7M.
  • Sivik Global Healthcare first reported a position in HCA Healthcare in Q4 2013 and held it in 45 quarters.
  • Sivik Global Healthcare's HCA Healthcare position peaked at $13.3M in Q3 2021.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Sivik Global Healthcare's 13F filing for Q1 2026, filed 15 Apr 2026.